Effect of telehealth on glycaemic control: analysis of patients with type 2 diabetes in the Whole Systems Demonstrator cluster randomised trial
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Whole Systems Demonstrator was a large, pragmatic, cluster randomised trial that compared telehealth with usual care among 3,230 patients with long-term conditions in three areas of England. Telehealth involved the regular transmission of physiological information such as blood glucose to health professionals working remotely. We examined whether telehealth led to changes in glycosylated haemoglobin (HbA1c) among the subset of patients with type 2 diabetes. METHODS: The general practice electronic medical record was used as the source of information on HbA1c. Effects on HbA1c were assessed using a repeated measures model that included all HbA1c readings recorded during the 12-month trial period, and adjusted for differences in HbA1c readings recorded before recruitment. Secondary analysis averaged multiple HbA1c readings recorded for each individual during the trial period. RESULTS: 513 of the 3,230 participants were identified as having type 2 diabetes and thus were included in the study. Telehealth was associated with lower HbA1c than usual care during the trial period (difference 0.21% or 2.3 mmol/mol, 95% CI, 0.04% to 0.38%, p = 0.013). Among the 457 patients in the secondary analysis, mean HbA1c showed little change for controls following recruitment, but fell for intervention patients from 8.38% to 8.15% (68 to 66 mmol/mol). A higher proportion of intervention patients than controls had HbA1c below the 7.5% (58 mmol/mol) threshold that was targeted by general practices (30.4% vs. 38.0%). This difference, however, did not quite reach statistical significance (adjusted odds ratio 1.63, 95% CI, 0.99 to 2.68, p = 0.053). CONCLUSIONS: Telehealth modestly improved glycaemic control in patients with type 2 diabetes over 12 months. The scale of the improvements is consistent with previous meta-analyses, but was relatively modest and seems unlikely to produce significant patient benefit. TRIAL REGISTRATION NUMBER: International Standard Randomized Controlled Trial Number Register ISRCTN43002091.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Austin, P. C. (2009) · Statistics in Medicine · doi:10.1002/sim.3697 · Cited by 6,758 · cited 1×
“For continuous variables, we also present the variance ratio, defined as the variance in the intervention group divided by the variance among controls [30].”
Intensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189 · cited 1×
“Thus, although some meta-analyses have found that intensive glycaemic control is associated with lower rates of major cardiovascular events in trials [45-47], another has suggested that the harms associated with severe hypoglycaemia might counterbalance the potential benefits of intensive glycaemic control [48].”
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
Currie, C. J., Peters, J. R., Tynan, A., Evans, M., Heine, R. J., Bracco, O. L., Zagar, T., & Poole, C. D. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61969-3 · Cited by 874
Boussageon, R., Bejan-Angoulvant, T., Saadatian-Elahi, M., Lafont, S., Bergeonneau, C., Kassai, B., Erpeldinger, S., Wright, J. M., Gueyffier, F., & Cornu, C. (2011) · BMJ · doi:10.1136/bmj.d4169 · Cited by 803
Steventon, A., Bardsley, M., Billings, J., Dixon, J., Doll, H., Hirani, S., Cartwright, M., Rixon, L., Knapp, M., Henderson, C., et al. (2012) · BMJ · doi:10.1136/bmj.e3874 · Cited by 583 · cited 8×
“The full WSD trial involved 3,230 patients from 179 general practices [19].”
InfluentialSelf-citationLiang, X., Wang, Q., Yang, X., Cao, J., Chen, J., Mo, X., Huang, J., Wang, L., & Gu, D. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03180.x · Cited by 515 · cited 1×
“In comparison to these meta-analyses, larger effect sizes where found in a review of telehealth interventions using mobile phones for patients [40].”
Sanders, C., Rogers, A., Bowen, R., Bower, P., Hirani, S., Cartwright, M., Fitzpatrick, R., Knapp, M., Barlow, J., Hendy, J., et al. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-220 · Cited by 450 · cited 3×
“Such high rates of patient refusal are not unusual for telehealth trials [35], and by themselves suggest that telehealth might not always meet the perceived needs of patients and that many patients may be reluctant to change from their current mode of care [23,36].”
Self-citationHenderson, C., Knapp, M., Fernandez, J.-L., Beecham, J., Hirani, S. P., Cartwright, M., Rixon, L., Beynon, M., Rogers, A., Bower, P., et al. (2013) · BMJ · doi:10.1136/bmj.f1035 · Cited by 364
Self-citationPuffer, S., Torgerson, D., & Watson, J. (2003) · BMJ · doi:10.1136/bmj.327.7418.785 · Cited by 351
Bower, P., Kontopantelis, E., Sutton, A., Kendrick, T., Richards, D. A., Gilbody, S., Knowles, S., Cuijpers, P., Andersson, G., Christensen, H., et al. (2013) · BMJ · doi:10.1136/bmj.f540 · Cited by 341
Research works printed but not linked: 32
- Bardsley M, Steventon A, Smith J, Dixon J: Evaluating Integrated and Community-Based Care: How Do We Know What Works?. 2013, London: Nuffield Trust
- Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR: Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012, 35: 1364-1379. · DOI · Paper page
- Stone MA, Charpentier G, Doggen K, Kuss O, Lindblad U, Kellner C, Nolan J, Pazderska A, Rutten G, Trento M, Khunti K: Quality of care of people with type 2 diabetes in eight European Countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study. Diabetes Care. 2013, 36: 2628-2638. · DOI · Paper page
- Virdi NS, Lefebvre P, Parisé H, Duh MS, Pilon D, Laliberté F, Sundaresan D, Garber L, Dirani R: Association of self-monitoring of blood glucose use on glycated hemoglobin and weight in newly diagnosed, insulin-naïve adult patients with type 2 diabetes. J Diabetes Sci Technol. 2013, 7: 1229-1242. · DOI
- West SP, Lagua C, Trief PM, Izquierdo R, Weinstock RS: Goal setting using telemedicine in rural underserved older adults with diabetes: experiences from the informatics for diabetes education and telemedicine project. Telemed J E Health. 2010, 16: 405-416. · DOI · Paper page
- Department of Health: Our Health, Our Care, Our Say: A New Direction for Community Services. Cm 6737. 2006, London: The Stationery Office
- Shea S, Weinstock RS, Starren J, Teresi J, Palmas W, Field L, Morin P, Goland R, Izquierdo RE, Wolff LT, Ashraf M, Hilliman C, Silver S, Meyer S, Holmes D, Petkova E, Capps L, Lantigua RA: A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus. J Am Med Inform Assoc. 2006, 13: 40-51. · DOI · Paper page
- Weinstock RS, Teresi JA, Goland R, Izquierdo R, Palmas W, Eimicke JP, Ebner S, Shea S: Glycemic control and health disparities in older ethnically diverse underserved adults with diabetes: five-year results from the Informatics for Diabetes Education and Telemedicine (IDEATel) study. Diabetes Care. 2011, 34: 274-279. · DOI · Paper page
- Shea S, Weinstock RS, Teresi JA, Palmas W, Starren J, Cimino JJ, Lai AM, Field L, Morin PC, Goland R, Izquierdo RE, Ebner S, Silver S, Petkova E, Kong J, Eimicke JP: A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study. J Am Med Inform Assoc. 2009, 16: 446-456. · DOI · Paper page
- Bower P, Cartwright M, Hirani SP, Barlow J, Hendy J, Knapp M, Henderson C, Rogers A, Sanders C, Bardsley M, Steventon A, Fitzpatrick R, Doll H, Newman S: A comprehensive evaluation of the impact of telemonitoring in patients with long-term conditions and social care needs: protocol for the whole systems demonstrator cluster randomised trial. BMC Health Serv Res. 2011, 11: 184. · DOI · Paper page
- Bergmo TS: Can economic evaluation in telemedicine be trusted? A systematic review of the literature. Cost Eff Resour Alloc. 2009, 7: 18. · DOI · Paper page
- Roland M, Torgerson DJ: Understanding controlled trials: What are pragmatic trials?. BMJ. 1998, 316: 285-285. · DOI · Paper page
- Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Beynon M, Hirani SP, Cartwright M, Rixon L, Knapp M, Henderson C, Rogers A, Hendy J, Fitzpatrick R, Newman S: Effect of telecare on use of health and social care services: findings from the Whole Systems Demonstrator cluster randomised trial. Age Ageing. 2013, 42: 501-508. · DOI · Paper page
- Hirani SP, Beynon M, Cartwright M, Rixon L, Doll H, Henderson C, Bardsley M, Steventon A, Knapp M, Rogers A, Bower P, Sanders C, Fitzpatrick R, Hendy J, Newman SP: The effect of telecare on the quality of life and psychological well-being of elderly recipients of social care over a 12-month period: the Whole Systems Demonstrator cluster randomised trial. Age Ageing. 2013, 43: 334-341. · DOI · Paper page
- MacNeill V, Sanders C, Fitzpatrick R, Hendy J, Barlow J, Knapp M, Rogers A, Bardsley M, Newman SP: Experiences of front-line health professionals in the delivery of telehealth: a qualitative study. Br J Gen Pract. 2014, 64: e401-e407. · DOI · Paper page
- DeMets DL: Current development in clinical trials: issues old and new. Stat Med. 2012, 31: 2944-2954. · DOI
- NHS Employers and General Practitioners Committee: Quality and Outcomes Framework Guidance for GMS Contract 2009 / 10. 2009, London: NHS Employers
- Bardsley M, Steventon A, Doll H: Impact of telehealth on general practice contacts: findings from the Whole Systems Demonstrator cluster randomised trial. BMC Health Serv Res. 2013, 13: 395. · DOI
- Imai K, King G, Stuart EA: Misunderstandings between experimentalists and observationalists about causal inference. J R Stat Soc Ser A (Stat Soc). 2008, 171: 481-502. · DOI · Paper page
- Frison L, Pocock SJ: Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med. 1992, 11: 1685-1704. · DOI · Paper page
- Wennberg D, Siegel M, Darin B, Filipova N, Russell R, Kenney L, Steinort K, Park T-R, Cakmakci G, Dixon J, Curry N, Billings J: Combined Predictive Model: Final Report and Technical Documentation. 2006, London: King's Fund
- Staa T-P v, Goldacre B, Gulliford M, Cassell J, Pirmohamed M, Taweel A, Delaney B, Smeeth L: Pragmatic randomised trials using routine electronic health records: putting them to the test. BMJ. 2012, 344: e55-e55. · DOI · Paper page
- Subramanian U, Hopp F, Lowery J, Woodbridge P, Smith D: Research in home-care telemedicine: challenges in patient recruitment. Telemed J E Health. 2004, 10: 155-161. · doi:10.1089/tmj.2004.10.155 · Paper page
- Wherton J, Sugarhood P, Procter R, Rouncefield M, Dewsbury G, Hinder S, Greenhalgh T: Designing assisted living technologies “in the wild”: preliminary experiences with cultural probe methodology. BMC Med Res Methodol. 2012, 12: 188. · DOI · Paper page
- Stuart EA, Cole SR, Bradshaw CP, Leaf PJ: The use of propensity scores to assess the generalizability of results from randomized trials. J R Stat Soc Ser A (Stat Soc). 2011, 174: 369-386. · DOI · Paper page
- McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P: The Hawthorne Effect: a randomised, controlled trial. BMC Med Res Methodol. 2007, 7: 30. · DOI · Paper page
- The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993, 329: 977-986. · DOI · Paper page
- Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW: 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008, 359: 1577-1589. · DOI · Paper page
- Govan L, Wu O, Briggs A, Colhoun HM, Fischbacher CM, Leese GP, McKnight JA, Philip S, Sattar N, Wild SH, Lindsay RS: Achieved levels of HbA1c and likelihood of hospital admission in people with type 1 diabetes in the Scottish population: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care. 2011, 34: 1992-1997. · DOI
- Ray KK, Seshasai SRK, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N: Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009, 373: 1765-1772. · DOI · Paper page
- Mannucci E, Monami M, Lamanna C, Gori F, Marchionni N: Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis. 2009, 19: 604-612. · DOI · Paper page
- Lipska KJ, Warton EM, Huang ES, Moffett HH, Inzucchi SE, Krumholz HM, Karter AJ: HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes. Diabetes Care. 2013, 36: 3535-3542. · DOI · Paper page
Cited by
Faruque, L. I., Wiebe, N., Ehteshami-Afshar, A., Liu, Y., Dianati-Maleki, N., Hemmelgarn, B. R., Manns, B. J., & Tonelli, M. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.150885 · Cited by 281
Sheon, A. R., Bolen, S. D., Callahan, B., Shick, S., & Perzynski, A. T. (2017) · JMIR Diabetes · doi:10.2196/diabetes.6751 · Cited by 62
Shen, Y., Wang, F., Zhang, X., Zhu, X., Sun, Q., Fisher, E., & Sun, X. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9133 · Cited by 54
“In the group of manual feedback [7,9-11,14,27-32,35,37,40,41,43,44,48-51,53], statistically significant difference in HbA1c between CG and IG was observed, and heterogeneity across studies was 67.”
BackgroundMethodInfluentialHangaard, S., Laursen, S. H., Andersen, J. D., Kronborg, T., Vestergaard, P., Hejlesen, O., & Udsen, F. W. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211064633 · Cited by 55
Robson, N., & Hosseinzadeh, H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182212171 · Cited by 55
“…= 0.3 (PTI) CI (−0.48, −0.04) p = 0.9 (PFI) CI (−0.41, 0.03) p = 0.3 (CBI) CI (−0.47, −0.03) Shea et al., 2013 Data obtained from Weinstock et al., 2011 Steventon et al., 2014 United Kingdom n = 513 Intervention (300) 53% Control (213) 64% Intervention 63.9 ± 13.0 Control 66.2 ±…”
Influential
Metadata
- Authors
- Steventon, A., Bardsley, M., Doll, H., Tuckey, E., & Newman, S. P.
- Venue
- BMC Health Services Research
- Published
- 2014-08-06
- Volume
- 14
- Issue
- 1
- Pages
- 334-334
- ISSN
- 1472-6963 (ISSN-L)
- OpenAlex
- W2139373808
- Cited by
- 40
- References
- 18
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of telehealth on glycaemic control: analysis of patients with type 2 diabetes in the Whole Systems Demonstrator cluster randomised trial. https://app.cochat.ai/papers/10.1186/1472-6963-14-334
- The paper
- Steventon, A., Bardsley, M., Doll, H., Tuckey, E., & Newman, S. P. (2014). Effect of telehealth on glycaemic control: analysis of patients with type 2 diabetes in the Whole Systems Demonstrator cluster randomised trial. BMC Health Services Research. https://doi.org/10.1186/1472-6963-14-334
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.